Beam Therapeutics To Present Updated Preclinical Data Highlighting 'Optimized' LNP Delivery Approaches For In Vivo Base Editing To The Liver And Other Tissues At TIDES USA Oligonucleotide & Peptide Therapeutics Conference Sept. 23